Natera

Natera

Biotechnology firm specializing in genetic testing

About Natera

Simplify's Rating
Why Natera is rated
B-
Rated C on Competitive Edge
Rated B on Growth Potential
Rated B on Differentiation

Industries

Biotechnology

Healthcare

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Austin, Texas

Founded

2004

Overview

Company Historically Provides H1B Sponsorship

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera also offers tests for family planning and prenatal screening, including the Panorama NIPT, which has conducted over 2 million tests. The company generates revenue through testing kits and services, often reimbursed by insurance, and provides genetic counseling for personalized patient support.

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
  • AI integration enhances accuracy and speed of Natera's cfDNA analysis.
  • Growing personalized medicine trend aligns with Natera's custom-built ctDNA tests.

What critics are saying

  • Increased competition from companies like Lantheus Holdings threatens market share.
  • Recent CFO stock sale may indicate concerns about Natera's financial health.
  • Multiple trial launches could strain resources and lead to operational challenges.

What makes Natera unique

  • Natera specializes in cell-free DNA testing for diverse medical needs.
  • Their Signatera test offers custom-built ctDNA solutions for cancer patients.
  • Natera's Panorama NIPT has achieved over 2 million tests conducted.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$1338.2M

Above

Industry Average

Funded Over

10 Rounds

Post IPO Equity funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Equity Funding Comparison
Coming Soon

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

5%
TXBN
Apr 24th, 2025
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera(TM) Genome MRD Test

Natera announces broad clinical launch of ultra-sensitive signatera(tm) genome MRD test.

Slater Sentinel
Apr 3rd, 2025
DnB Asset Management AS Invests $235,000 in Natera, Inc. (NASDAQ:NTRA)

DnB Asset Management AS invests $235,000 in Natera, Inc. (NASDAQ:NTRA).

TXBN
Mar 25th, 2025
DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting

AUSTIN, Texas - (BUSINESS WIRE) - Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that it will share results from the DEFINE-HT study in a late-breaking oral presentation at the International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting on April 29, 2025.

Simply Wall St
Mar 13th, 2025
Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board

Last week, Natera (NasdaqGS:NTRA) announced a strategic expansion of its Board of Directors with the appointment of Monica Bertagnolli.

Investing.com
Mar 10th, 2025
Natera launches HEROES trial for breast cancer treatment

Natera launches HEROES trial for breast cancer treatment.

Recently Posted Jobs

Sign up to get curated job recommendations

PRN phlebotomist

Newport News, VA, USA

Histotechnologist

$50 - $60/hr

San Carlos, CA, USA

PRN phlebotomist

Fairfax, VA, USA

See All Jobs

Natera is Hiring for 260 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Natera's jobs every few hours, so check again soon! Browse all jobs →

People Also Viewed

Discover companies similar to Natera

Invitae

Invitae

San Francisco, California

Probably Genetic

Probably Genetic

San Francisco, California

Guardant Health

Guardant Health

Palo Alto, California

Histotechnologist

$50 - $60/hr

San Carlos, CA, USA

PRN phlebotomist

Fairfax, VA, USA

See All Jobs

Natera is Hiring for 260 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Natera's jobs every few hours, so check again soon! Browse all jobs →

People Also Viewed

Discover companies similar to Natera

Invitae

Invitae

San Francisco, California

Probably Genetic

Probably Genetic

San Francisco, California

Guardant Health

Guardant Health

Palo Alto, California